Allianz Asset Management Gmb H United Therapeutics Corp Transaction History

Allianz Asset Management Gmb H

  • $70.3 Billion
  • Q1 2025

A detailed history of Allianz Asset Management Gmb H transactions in United Therapeutics Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 67,576 shares of UTHR stock, worth $21.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
67,576
Previous 34,322 96.89%
Holding current value
$21.3 Million
Previous $12.1 Million 72.01%
% of portfolio
0.03%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
BUY
$304.42 - $380.78 $10.1 Million - $12.7 Million
33,254 Added 96.89%
67,576 $20.8 Million
Q4 2024

Feb 03, 2025
SELL
$348.66 - $410.0 $5.54 Million - $6.51 Million
-15,877 Reduced 31.63%
34,322 $12.1 Million
Q3 2024

Nov 12, 2024
BUY
$311.04 - $363.55 $1.63 Million - $1.9 Million
5,231 Added 11.63%
50,199 $18 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $2.63 Million - $3.67 Million
11,503 Added 34.37%
44,968 $14.3 Million
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $674,010 - $797,932
3,198 Added 10.57%
33,465 $7.69 Million
Q4 2023

Feb 12, 2024
BUY
$214.88 - $256.94 $517,645 - $618,968
2,409 Added 8.65%
30,267 $6.66 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $2.73 Million - $3.2 Million
-12,900 Reduced 31.65%
27,858 $6.29 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $41.2 Million - $46.7 Million
-200,626 Reduced 83.11%
40,758 $9 Million
Q1 2023

May 11, 2023
BUY
$212.99 - $276.17 $10.8 Million - $14.1 Million
50,888 Added 26.71%
241,384 $54.1 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $5.16 Million - $7.03 Million
-25,060 Reduced 11.63%
190,496 $53 Million
Q3 2022

Nov 08, 2022
BUY
$203.3 - $244.17 $2.53 Million - $3.03 Million
12,425 Added 6.12%
215,556 $45.1 Million
Q2 2022

Aug 12, 2022
BUY
$174.81 - $241.14 $4.88 Million - $6.73 Million
27,922 Added 15.94%
203,131 $47.9 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $15 Million - $19.3 Million
-90,029 Reduced 33.94%
175,209 $31.4 Million
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $17.3 Million - $20.3 Million
93,847 Added 54.76%
265,238 $57.3 Million
Q3 2021

Nov 10, 2021
BUY
$179.86 - $214.88 $12 Million - $14.3 Million
66,474 Added 63.36%
171,391 $31.6 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $9.65 Million - $12 Million
56,599 Added 117.14%
104,917 $18.8 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $4.13 Million - $4.69 Million
26,830 Added 124.86%
48,318 $8.08 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $292,061 - $435,181
-2,867 Reduced 11.77%
21,488 $3.26 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $2.12 Million - $2.57 Million
-21,232 Reduced 46.57%
24,355 $2.46 Million
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $361,036 - $489,817
-3,893 Reduced 7.87%
45,587 $5.52 Million
Q1 2020

May 14, 2020
BUY
$79.39 - $115.35 $1.85 Million - $2.69 Million
23,316 Added 89.11%
49,480 $4.69 Million
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $409,952 - $499,104
5,235 Added 25.01%
26,164 $2.31 Million
Q3 2019

Nov 13, 2019
SELL
$74.85 - $85.99 $5.51 Million - $6.32 Million
-73,552 Reduced 77.85%
20,929 $1.67 Million
Q2 2019

Aug 08, 2019
SELL
$76.06 - $120.81 $843,277 - $1.34 Million
-11,087 Reduced 10.5%
94,481 $7.38 Million
Q1 2019

May 13, 2019
SELL
$107.15 - $126.84 $261,124 - $309,109
-2,437 Reduced 2.26%
105,568 $12.4 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $675,019 - $856,955
6,657 Added 6.57%
108,005 $11.8 Million
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $7.25 Million - $8.24 Million
63,664 Added 168.94%
101,348 $13 Million
Q2 2018

Aug 13, 2018
SELL
$101.14 - $118.31 $308,375 - $360,727
-3,049 Reduced 7.49%
37,684 $4.26 Million
Q1 2018

May 14, 2018
BUY
$107.21 - $151.94 $45,028 - $63,814
420 Added 1.04%
40,733 $4.58 Million
Q4 2017

Feb 13, 2018
SELL
$118.58 - $151.28 $5.19 Million - $6.62 Million
-43,751 Reduced 52.04%
40,313 $5.96 Million
Q3 2017

Nov 13, 2017
SELL
$114.6 - $136.81 $384,712 - $459,271
-3,357 Reduced 3.84%
84,064 $9.85 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-6,816 Reduced 7.23%
87,421 $11.4 Million
Q1 2017

Apr 17, 2019
SELL
N/A
-2,662 Reduced 2.75%
94,237 $12.8 Million
Q4 2016

Apr 17, 2019
SELL
N/A
-9,621 Reduced 9.03%
96,899 $13.9 Million
Q3 2016

Apr 17, 2019
BUY
N/A
106,520
106,520 $12.4 Million

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email